, Volume 33, Issue 1, pp 72–74 | Cite as

Ultrastructural evidence of amantadine and amphetamine noradrenaline releasing action

  • Elena Pita
  • Nicolas Perez


Amantadine, like amphetamine, exerts a depletory effect upon noradrenaline containing vesicles of the adrenal medulla. The microtubular system seems to play a role in the releasing process.


Noradrenaline Amphetamine Amantadine Adrenal Medulla Depletory Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 2.
    V. G. Vernier, J. B. Harmon, J. M. Stump, T. E. Lynes, J. P. Marvel andD. H. Smith, Toxic. Appl. Pharmac.15, 642 (1969).CrossRefGoogle Scholar
  2. 3.
    L. O. Farnebo, K. Fuxe, M. Goldstein, B. Hamberger andU. Ungerstedt; Eur. J. Pharmac.16, 27 (1971).CrossRefGoogle Scholar
  3. 4.
    E. A. Fletcher andP. H. Redfern, J. Pharm. Pharmac.22, 957 (1970).Google Scholar
  4. 5.
    R. F. Grelak, R. Clark, J. M. Stump andV. G. Vernier, Science169, 203 (1970).PubMedGoogle Scholar
  5. 6.
    R. L. H. Heimans, M. J. Rand andM. R. Fennessy, J. Pharm. Pharmac.24, 875 (1972).Google Scholar
  6. 7.
    W. R. Herblin, Biochem. Pharmac.21, 1993 (1972).CrossRefGoogle Scholar
  7. 8.
    B. Scatton, A. Cheramy, M. J. Besson andJ. Glowinski, Eur. J. Pharmac.13, 131 (1970).CrossRefGoogle Scholar
  8. 9.
    U. Stromberg, T. H. Svensson andB. Waldeck, J. Pharm. Pharmac.23, 959 (1970).Google Scholar
  9. 10.
    P. F. von Voigtlander andK. E. Moore, Science174 (1971).Google Scholar
  10. 11.
    P. F. von Voigtlander andK. E. Moore, J. Pharmac. exp. Ther.184, 542 (1972).Google Scholar
  11. 12.
    R. J. Baldessarini, J. F. Lipinski andK. V. Chace, Biochem. Pharmac.21, 77 (1972).CrossRefGoogle Scholar
  12. 13.
    S. Symchowicz, C. A. Korduba andJ. Veals, Eur. J. Pharmac.21, 155 (1973).CrossRefGoogle Scholar
  13. 14.
    R. Papeschi, Neuropharmacology13, 381 (1974).CrossRefGoogle Scholar
  14. 15.
    T. W. Stone andE. V. Bailey, Brain Res.85, 126 (1975).CrossRefPubMedGoogle Scholar
  15. 16.
    B. Cox andC. S. William, Br. J. Pharmac., suppl. 575 (1972).Google Scholar
  16. 17.
    R. L. H. Heimans, M. J. Rand andM. R. Fennessy, J. Pharm. Pharmac.24, 869 (1972).Google Scholar
  17. 18.
    A. Mundo Salyador, Eur. J. Pharmac.31, 38 (1975).CrossRefGoogle Scholar
  18. 19.
    J. G. Sinclair, Can. J. Physiol. Pharmac.51, 305 (1973).Google Scholar
  19. 20.
    J. B. Lassen, Psycopharmacologia29, 55 (1973).CrossRefGoogle Scholar
  20. 21.
    F. H. Schneider, J. Pharmac. exp. Ther.183, 80 (1972).Google Scholar
  21. 22.
    G. Millonig, J. Biophys. Biochem. Cytol.11, 736 (1961).PubMedGoogle Scholar
  22. 23.
    J. D. Clinton, Plastics, New York65 (1971).Google Scholar
  23. 24.
    E. S. Reynolds, J. Cell. Biol.17, 208 (1963).PubMedGoogle Scholar
  24. 25.
    D. J. Smith andL. S. van Orden, Neuropharmacology12, 875 (1973).CrossRefPubMedGoogle Scholar
  25. 26.
    J. M. Trifaro, B. Collier andA. Lastowecka, Mol. Pharmac.8, 264 (1972).Google Scholar
  26. 27.
    A. M. Poisner andJ. Bernstein, J. Pharmac. exp. Ther.177, 102 (1971).Google Scholar
  27. 28.
    R. G. Rahwan, J. L. Borowitz andE. J. Hinsman, Arch. int. Pharmacodyn.206, 345 (1973).PubMedGoogle Scholar
  28. 29.
    D. A. Redburn, A. M. Poisner andE. F. Samson, Jr., Brain Res.44, 615 (1972).CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser Verlag 1977

Authors and Affiliations

  • Elena Pita
    • 1
  • Nicolas Perez
    • 1
  1. 1.Department of Pharmacology, Faculty of MedicineUniversity of GranadaGranadaSpain

Personalised recommendations